mobocertinib
takeda
['sclc', 'lcsm,(-blcsm)', 'mobocertinib', 'nsclc']
mobocertinib may have limited intracranial activity in egfr exon 20 insertion+ nsclc with baseline brain mets #asco22 #lcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.